TEANECK, New Jersey and LONDON, October 23 /PRNewswire/ --
- New global services agreement covers a wide range of application services for AstraZeneca's Research, Clinical Development and Sales and Marketing functions
Cognizant (Nasdaq: CTSH), a leading provider of consulting, technology and business process outsourcing services, today announced a five-year agreement with AstraZeneca to provide application maintenance services to AstraZeneca's global enterprise in the business-critical areas of research, clinical development, and sales and marketing. The agreement will further expand Cognizant's long-standing relationship with the pharmaceutical major.